Page last updated: 2024-10-24

chloroquine and Afibrinogenemia

chloroquine has been researched along with Afibrinogenemia in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Afibrinogenemia: A deficiency or absence of FIBRINOGEN in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howard, HF1

Other Studies

1 other study available for chloroquine and Afibrinogenemia

ArticleYear
Peripheral clinical laboratory service for the Border and Transkei.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973, Feb-24, Volume: 47, Issue:8

    Topics: Afibrinogenemia; Amebiasis; Balantidiasis; Black or African American; Black People; Cantharidin; Chi

1973